Target Price | $17.22 |
Price | $5.64 |
Potential |
205.36%
register free of charge
|
Number of Estimates | 9 |
9 Analysts have issued a price target Voyager Therapeutics, Inc. 2025 .
The average Voyager Therapeutics, Inc. target price is $17.22.
This is
205.36%
register free of charge
$30.00
431.91%
register free of charge
$7.00
24.11%
register free of charge
|
|
A rating was issued by 10 analysts: 9 Analysts recommend Voyager Therapeutics, Inc. to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Voyager Therapeutics, Inc. stock has an average upside potential 2025 of
205.36%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 250.01 | 86.21 |
511.12% | 65.52% | |
EBITDA Margin | 50.58% | -77.60% |
146.35% | 253.41% | |
Net Margin | 64.79% | -63.33% |
140.16% | 197.75% |
9 Analysts have issued a sales forecast Voyager Therapeutics, Inc. 2024 . The average Voyager Therapeutics, Inc. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Voyager Therapeutics, Inc. EBITDA forecast 2024. The average Voyager Therapeutics, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Voyager Therapeutics, Inc. Analysts have issued a net profit forecast 2024. The average Voyager Therapeutics, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | 2.97 | -1.00 |
345.45% | 133.67% | |
P/E | negative | |
EV/Sales | 0.09 |
9 Analysts have issued a Voyager Therapeutics, Inc. forecast for earnings per share. The average Voyager Therapeutics, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Voyager Therapeutics, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Voyager Therapeutics, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.